WeWork preps for IPO with growing revenues and widening losses
August 14, 2019Macy’s not looking to raise prices if new tariffs imposed: CEO
August 14, 2019Novartis says Avexis’ Chief Science Officer, head of R&D no longer at company
at
Novartis said on Wednesday that the chief science officer and top research and development executive at its Avexis unit are no longer at the company after some data from early testing of the unit’s more than $2 million gene therapy Zolgensma was manipulated.
Powered by WPeMatico
